Skip to main content
Smart Investors Daily
TY

NASDAQ · TYHT

Shineco, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

$11.09

Down-$0.45 (-3.90%)

Updated Aug 23, 2026, 11:13 AM

SID Score

Composite research score

Smart Money

Institutional and insider signal

Market cap
229.17M
P/E ratio
-0
Dividend yield
0.00%
52-week range
— – —
Volume
34.58K
Avg. volume
212.92K

Price performance

TYHT price history

1M range · 0 trading sessions · Daily adjusted prices

TYHT does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest TYHT news

The latest Smart Investors Daily articles mentioning TYHT.

TYHT research

Overview

Company profile and research snapshot.

Company profile

Shineco, Inc. is a holding company, which through its subsidiaries, engages in the production and distribution of plant-based products. The company is headquartered in Beijing, Beijing and currently employs 380 full-time employees. The firm provides health and well-being focused plant-based products by using its subsidiaries' and variable interest entities' vertically- and horizontally-integrated production, distribution and sales channels. The firm operates through three segments: developing, manufacturing and distributing of specialized fabrics, textile products and other by-products derived from an indigenous Chinese plant called Apocynum Venetum, known as Bluish Dogbane (Luobuma); planting, processing and distributing of traditional Chinese medicinal herbal products, as well as other pharmaceutical products (Herbal products), and planting, processing and distributing of green and organic agricultural produce, as well as growing and cultivating of Chinese Yew trees (Agricultural products). The company utilizes engineering technologies and biotechnologies to produce, among other products, Chinese herbal medicines, organic agricultural produce and specialized textiles.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
Implied upside
Analysts
Open full forecast

News briefing

No generated briefing is available yet.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.